Hematological Malignancies

Cardiovascular disease after therapy for HL: A detailed analysis of 9 collaborative EORTC-LYSA trials

• Incidence of CVD was reported during follow-up and updated through a patient-reported questionnaire, mailed in 2009–2010

Maraldo et al, Lancet Hemat in press